Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - November 2013


2nd Annual Cell Culture & Bioprocessing Congress 2013

04 Nov 2013 - 05 Nov 2013



Bookmark and Share


200 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions

50 presentations, case studies and panel discussions focused on the key issues in cell line optimisation, process development and biological production

Oxford Global Conferences are proud to present our 2nd Annual Cell Culture & Bioprocessing Congress, taking place on 4th & 5th November, 2013 at the Copthorne Tara Hotel London Kensington.

This congress offers invaluable insights into key technological and scientific advances, addressing the most pressing challenges in the cell culture industry.

Over two days, the congress will attract over 200 senior-level decision makers working at the forefront of the cell culture and bioprocessing industry from the US and Europe. The conference programme consists of world-class keynote addresses, industry and academic led presentations and panel debates as well as ample networking opportunities, creating an interactive platform for high-level scientific and business discussion.

On Day One, our panel of cell culture experts will discuss the latest methods in cell line engineering and advances in cell culture development. Presentations will cover the critical issues in downstream processing, developing a successful cell fermentation process and achieving reliable process characterisation.

Day Two will feature case studies on the opportunities and challenges in 3D cell culture and cell media, and the latest insights into optimising cell line performance, quality and stability. Our internationally renowned speakers will also discuss quality by design, raw material management and single use technologies.

Co-located with the Stem Cell Congress, this event is a must attend for anyone working in cell culture and bioprocessing.



Further information
Scientific News
Envigo Rat Models Proven to be Susceptible to Intra-Vaginal HSV-2 Infection and Protectable
Scientific findings establish the effectiveness of new approach to investigate the protective effects of vaccine candidates and anti-viral microbodies and to study asymptomatic primary genital HSV-2 infection.
Drug that Activates Innate Immune System Identified
Researchers from the institute have identified a drug, which is straightforward to synthesize and to couple to antigens that induce an immune response and may prove useful in the generation of vaccines.
Valvena, GSK Sign New R&D Collaboration
Valneva to supply process development services for EB66® -based Influenza vaccines.
Counting Cancer-busting Oxygen Molecules
Researchers from the Centre for Nanoscale BioPhotonics (CNBP), an Australian Research Centre of Excellence, have shown that nanoparticles used in combination with X-rays, are a viable method for killing cancer cells deep within the living body.
Therapeutic Approach Gives Hope for Multiple Myeloma
A new therapeutic approach tested by a team from Maisonneuve-Rosemont Hospital (CIUSSS-EST, Montreal) and the University of Montreal gives promising results for the treatment of multiple myeloma, a cancer of the bone marrow currently considered incurable with conventional chemotherapy and for which the average life expectancy is about 6 or 7 years.
Protein Protects Against Flu in Mice
The engineered molecule doesn’t provoke inflammation and may hail a new class of antivirals.
Crowdfunding the Fight Against Cancer
From budding social causes to groundbreaking businesses to the next big band, crowdfunding has helped connect countless worthy projects with like-minded people willing to support their efforts, even in small ways. But could crowdfunding help fight cancer?
Natural Protein Points to New Inflammation Treatment
Findings may offer insight to effective treatments for inflammatory diseases, such as rheumatoid arthritis, psoriasis, and multiple sclerosis.
Tricked-Out Immune Cells Could Attack Cancer
New cell-engineering technique may lead to precision immunotherapies.
Therapy Halts Progression of Lou Gehrig’s Disease
Researchers at Oregon State University announced today that they have essentially stopped the progression of amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, for nearly two years in one type of mouse model used to study the disease – allowing the mice to approach their normal lifespan.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!